Objective
=========

To study the effectiveness of ATIII in critically ill septic patients with DIC.

Design
======

Prospective observational study.

Settings
========

An 8 bed medical-surgical ICU of a general hospital.

Patients
========

Septic adult patients with findings of DIC during a 1 year period.

Methods
=======

A total of 45 patients (age 21--72) fulfilling the classical criteria of sepsis and DIC having similar APACHE II and MODS scores at admission were studied. These patients divided in two groups A and B including 23 and 22 patients respectively. Group A: All patients received ATIII in a loading dose (BW × \[100 --Laboratory Value ATIII% × 2/3\]) when ATIII levels in blood measured \<60%. Blood derivatives were used when PTL \<20,000 mm^3^, PT \>20 s, fibrinogen \<1 g/l and D-Dimers \>500 μg/l. Group B: Patients were treated according to the classical treatment. Hematological parameters Ht, Hb, PTL, WBC, PT, PTT, ATIII, Fibrinogen, D-Dimers, were measured every 8 h until their improvement and restoration.

Results
=======

A significant differences in improvement of hematological parameters were observed between the two groups. In group A after a single dose of ATIII the values of PT (19.7 ± 2.5 vs 26.6 ± 4.1), PTT (49.4 ± 5.2 vs 54.9 ± 8.9), ATIII (70 ± 6 vs 37.6 ± 4.7), Fibrinogen (161 ± 18 vs 104 ± 14) and D-Dimers (177 ± 21 vs 264 ± 31) improved significantly after 12 h (*P* \<0.05 for all comparisons). In 16/23 (Group A) patients received a single dose of ATIII, hematological disorders restored in first 32 h. The rest 7/23 patients needed a second dose in 48 h. In group B the hematological disorders remained for at least 5 days and restored beyond the 10th day.

Conclusions
===========

The use of ATIII seems to be critical for the rapid improvement and stabilization in septic patients with hematological disorders.
